SCHEMBL14239269

SCHEMBL14239269

Cc1nc(C(=O)O)cn1-c1ccc(N)cn1

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CHRM4 P08173 1/20 0.36
KDM4E B2RXH2 2/20 0.36
ALDH1A1 P00352 1/20 0.34
HPGD P15428 1/20 0.34
ALOX15 P16050 1/20 0.34
HSD17B10 Q99714 1/20 0.34
GABRA2 P47869 2/20 0.33
GABRB2 P47870 2/20 0.33
RXFP1 Q9HBX9 1/20 0.32
PTGS1 P23219 1/20 0.32
PTGS2 P35354 1/20 0.32
AKR1B1 P15121 1/20 0.31
GRIN2D O15399 1/20 0.31
GRIN3B O60391 1/20 0.31
GRIN1 Q05586 1/20 0.31
GRIN2A Q12879 1/20 0.31
GRIN2B Q13224 1/20 0.31
GRIN2C Q14957 1/20 0.31
GRIN3A Q8TCU5 1/20 0.31
CCNA2 P20248 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14167787 0.80 CHRM4 (0.53) CHRM4KDM4EALDH1A1
SCHEMBL29205287 0.79 TUBB4A (0.38) KDM4EALDH1A1HPGDHSD17B10GRIN2D
SCHEMBL14239265 0.72 KDM4E (0.51) CHRM4KDM4E
SCHEMBL21314950 0.70 NOTUM (0.50) KDM4EALDH1A1HPGDALOX15HSD17B10
SCHEMBL25004848 0.69 RXFP1 (0.41) KDM4EALDH1A1HPGDALOX15HSD17B10
Methylamine SCHEMBL3235636 0.69 P4HTM (0.55) KDM4EALDH1A1ALOX15NAPRTHCAR2
SCHEMBL31359466 0.69 P4HTM (0.59) KDM4EALDH1A1ALOX15GABRA2GABRB2
SCHEMBL249720 0.69 P4HTM (0.59) KDM4EALDH1A1ALOX15GABRA2GABRB2
SCHEMBL21713058 0.68 CYP2E1 (0.47) ALDH1A1GABRA2GABRB2PTGS2HCAR2
SCHEMBL3745779 0.67 CYP3A4 (0.46) ALDH1A1GRIN2DGRIN3BGRIN1GRIN2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2012168315-A1 SUBSTITUTED PIPERIDINES AS GPR119 MODULATORS FOR THE TREATMENT OF METABOLIC DISORDERS BOEHRINGER INGELHEIM INTERNATIONAL GMBH (DE) 2012-12-13 WO disclosed